Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04337684 · ClinicalTrials.gov registry record
Long Term Follow-up on Menkes Disease Patients
A clinical trial of Menkes Disease, sponsored by Sentynl Therapeutics.
- Active
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04337684 is a study of Menkes Disease that is active but no longer recruiting, run by Sentynl Therapeutics. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04337684, a study of Menkes Disease, is active but no longer recruiting, sponsored by Sentynl Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will collect long term follow-up data regarding overall survival and neurological parameters from patients previously identified and/or enrolled in Protocols 09-CH-0059 and 90-CH0149 and Historical Control data on Menkes disease patients.
Conditions Studied
Interventions
- DRUG Long Term Follow-Up
Study Locations (1)
California
- Sentynl Therapeutics - Solana Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2026-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04337684
The ClinicalTrials.gov registry entry for NCT04337684 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sentynl Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Menkes Disease appearing as the primary indexed condition, and to 1 intervention - of which Long Term Follow-Up is the first listed.
NCT04337684 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04337684 about?
NCT04337684 is a clinical study titled "Long Term Follow-up on Menkes Disease Patients". This study will collect long term follow-up data regarding overall survival and neurological parameters from patients previously identified and/or enrolled in Protocols 09-CH-0059 and 90-CH0149 and Historical Control data on Menkes disease patients.
What is the current status of trial NCT04337684?
This trial is currently active not recruiting. The enrollment target is 50 participants. The study started on 2019-12-01. Estimated completion is 2026-08-31.
What conditions does trial NCT04337684 study?
This clinical trial studies the following conditions: Menkes Disease.
What interventions are being tested in trial NCT04337684?
The interventions under investigation include: Long Term Follow-Up (DRUG).
Who is sponsoring clinical trial NCT04337684?
This trial is sponsored by Sentynl Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04337684 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menkes Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.